Biorithm
PrivateLast Round
Series A
Dec 18, 2023
Total Funding Raised
$3.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Biorithm is a medical technology company that provides a remote maternal-fetal monitoring platform for personalized and connected maternity care.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Healthcare Analytics, Telemedicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biorithm Comparables
Compare Biorithm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bloomlife | 91% | |
| Marani Health | 85% | |
| Kali Healthcare | 83% | |
Biorithm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 18, 2023 | ||||
| Accelerator | Jun 29, 2016 |
Biorithm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SEEDS Capital | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors grew 2950% MoM, from 38 to 1.2K.
- Dec 18, 2023
$4M Series A round completed.
Biorithm Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biorithm's valuation, stock price, and market status.